Sofosbuvir and velpatasvir are antiviral medications that prevent hepatitis C virus (HCV) from multiplying in your body.

Sofosbuvir and velpatasvir is a combination medicine used to treat chronic hepatitis C in adults.

This medicine is sometimes given in combination with another antiviral medicine called ribavirin in people who also have advanced cirrhosis.

Sofosbuvir and velpatasvir treats specific genotypes of hepatitis C, and only in certain people. Use only the medications prescribed for you. Do not share your medicine with other people.

Uses: For the treatment of chronic HCV genotype 1 2 3 4 5 or 6 infection

-In patients without cirrhosis or with compensated cirrhosis
-In combination with ribavirin: In patients with decompensated cirrhosis

1 tablet orally once a day Recommended Regimen and Duration of Therapy:

-Therapy-naive and therapy-experienced without cirrhosis and with compensated cirrhosis (Child-Pugh A): Sofosbuvir-velpatasvir for 12 weeks
-Therapy-naive and therapy-experienced with decompensated cirrhosis (Child-Pugh B or C): Sofosbuvir-velpatasvir plus ribavirin for 12 weeks